Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prosthesis-Related Infections | 3 | 2019 | 34 | 1.310 |
Why?
|
| Fertility Preservation | 2 | 2021 | 11 | 1.290 |
Why?
|
| Penile Prosthesis | 3 | 2019 | 5 | 1.250 |
Why?
|
| Penile Implantation | 2 | 2019 | 4 | 1.220 |
Why?
|
| Fertilization in Vitro | 3 | 2020 | 85 | 0.920 |
Why?
|
| Semen Analysis | 2 | 2020 | 20 | 0.830 |
Why?
|
| Infertility, Male | 3 | 2020 | 57 | 0.830 |
Why?
|
| Aneuploidy | 2 | 2020 | 42 | 0.800 |
Why?
|
| Spermatozoa | 2 | 2020 | 258 | 0.700 |
Why?
|
| Infertility | 1 | 2021 | 31 | 0.690 |
Why?
|
| Paternal Age | 1 | 2019 | 2 | 0.640 |
Why?
|
| Trisomy | 1 | 2019 | 21 | 0.630 |
Why?
|
| Penile Diseases | 1 | 2019 | 7 | 0.620 |
Why?
|
| Penis | 1 | 2019 | 32 | 0.610 |
Why?
|
| Blastocyst | 1 | 2019 | 72 | 0.610 |
Why?
|
| Hypogonadism | 1 | 2018 | 14 | 0.590 |
Why?
|
| Seminoma | 1 | 2018 | 1 | 0.590 |
Why?
|
| Sperm Retrieval | 1 | 2018 | 1 | 0.590 |
Why?
|
| Testicular Neoplasms | 1 | 2018 | 33 | 0.570 |
Why?
|
| Hematoma | 1 | 2018 | 79 | 0.570 |
Why?
|
| Testosterone | 1 | 2018 | 121 | 0.560 |
Why?
|
| Microscopy | 1 | 2018 | 91 | 0.550 |
Why?
|
| TRPC Cation Channels | 2 | 2012 | 11 | 0.480 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2014 | 6 | 0.470 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 20 | 0.460 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 35 | 0.450 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 404 | 0.440 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2012 | 57 | 0.390 |
Why?
|
| Neoplasms | 1 | 2021 | 1350 | 0.340 |
Why?
|
| Male | 14 | 2023 | 29603 | 0.330 |
Why?
|
| Humans | 16 | 2023 | 62942 | 0.240 |
Why?
|
| Watchful Waiting | 2 | 2015 | 28 | 0.230 |
Why?
|
| Pregnancy | 3 | 2020 | 2318 | 0.220 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2023 | 27 | 0.220 |
Why?
|
| Pancreatitis, Chronic | 1 | 2023 | 19 | 0.220 |
Why?
|
| Pregnancy Rate | 2 | 2019 | 31 | 0.200 |
Why?
|
| NFATC Transcription Factors | 2 | 2012 | 20 | 0.180 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2021 | 35 | 0.180 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 34 | 0.170 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2020 | 33 | 0.170 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 67 | 0.160 |
Why?
|
| Risk Factors | 3 | 2019 | 5312 | 0.160 |
Why?
|
| Teratozoospermia | 1 | 2019 | 1 | 0.160 |
Why?
|
| Preimplantation Diagnosis | 1 | 2019 | 5 | 0.160 |
Why?
|
| Oocyte Donation | 1 | 2019 | 7 | 0.160 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 26 | 0.160 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2019 | 32 | 0.160 |
Why?
|
| Abortion, Spontaneous | 1 | 2019 | 31 | 0.160 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2018 | 3 | 0.150 |
Why?
|
| Prostatic Diseases | 1 | 2018 | 9 | 0.150 |
Why?
|
| Lasers, Solid-State | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cysts | 1 | 2018 | 41 | 0.150 |
Why?
|
| Testosterone Congeners | 1 | 2018 | 2 | 0.150 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 28 | 0.150 |
Why?
|
| Gonadotropins | 1 | 2018 | 14 | 0.150 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2018 | 17 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2019 | 133 | 0.150 |
Why?
|
| Aromatase Inhibitors | 1 | 2018 | 24 | 0.150 |
Why?
|
| Orchiectomy | 1 | 2018 | 33 | 0.150 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 29 | 0.150 |
Why?
|
| Cryopreservation | 1 | 2018 | 29 | 0.140 |
Why?
|
| Biopsy | 1 | 2019 | 431 | 0.140 |
Why?
|
| Varicocele | 1 | 2017 | 5 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2018 | 106 | 0.140 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 72 | 0.140 |
Why?
|
| Quality of Life | 2 | 2023 | 1216 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2018 | 95 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2021 | 421 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2018 | 190 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2018 | 368 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 55 | 0.130 |
Why?
|
| Testis | 1 | 2017 | 143 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 877 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 150 | 0.130 |
Why?
|
| Adult | 5 | 2019 | 16669 | 0.130 |
Why?
|
| TRPC6 Cation Channel | 2 | 2012 | 6 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1374 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2014 | 163 | 0.110 |
Why?
|
| Disease Progression | 2 | 2015 | 1160 | 0.100 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2012 | 67 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 126 | 0.100 |
Why?
|
| Mutation | 2 | 2012 | 2607 | 0.100 |
Why?
|
| Female | 4 | 2023 | 32597 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1293 | 0.090 |
Why?
|
| Chromosomes, Insect | 1 | 2010 | 8 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2012 | 617 | 0.080 |
Why?
|
| Genome, Insect | 1 | 2010 | 31 | 0.080 |
Why?
|
| Podocytes | 1 | 2009 | 10 | 0.080 |
Why?
|
| RNA Interference | 1 | 2012 | 618 | 0.080 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2009 | 17 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 908 | 0.080 |
Why?
|
| Protein Binding | 1 | 2012 | 1607 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2019 | 5606 | 0.070 |
Why?
|
| United States | 1 | 2021 | 7758 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 319 | 0.070 |
Why?
|
| Drosophila | 1 | 2010 | 433 | 0.070 |
Why?
|
| Arabidopsis | 1 | 2007 | 83 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2012 | 3027 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 1365 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 384 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2446 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2023 | 990 | 0.040 |
Why?
|
| Birth Rate | 1 | 2019 | 3 | 0.040 |
Why?
|
| Sperm Count | 1 | 2019 | 15 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2019 | 49 | 0.040 |
Why?
|
| Ejaculatory Ducts | 1 | 2018 | 1 | 0.040 |
Why?
|
| Holmium | 1 | 2018 | 2 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2018 | 8 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 70 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 190 | 0.040 |
Why?
|
| Causality | 1 | 2017 | 58 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 65 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 6556 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 290 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2658 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 242 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 419 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1117 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 1182 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 787 | 0.020 |
Why?
|
| Synteny | 1 | 2010 | 23 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2010 | 26 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2010 | 19 | 0.020 |
Why?
|
| Euchromatin | 1 | 2010 | 16 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2010 | 84 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2010 | 90 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 336 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2010 | 88 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 287 | 0.020 |
Why?
|
| Chromones | 1 | 2009 | 19 | 0.020 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2009 | 23 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 33 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2547 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 77 | 0.020 |
Why?
|
| Benzylamines | 1 | 2009 | 30 | 0.020 |
Why?
|
| Calcineurin | 1 | 2009 | 47 | 0.020 |
Why?
|
| Morpholines | 1 | 2009 | 88 | 0.020 |
Why?
|
| Glycosylation | 1 | 2009 | 138 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 141 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 171 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2009 | 126 | 0.020 |
Why?
|
| DNA, Plant | 1 | 2007 | 7 | 0.020 |
Why?
|
| Chromosomes, Plant | 1 | 2007 | 3 | 0.020 |
Why?
|
| Genes, Plant | 1 | 2007 | 20 | 0.020 |
Why?
|
| RNA, Plant | 1 | 2007 | 13 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2007 | 20 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 262 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 692 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 373 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 191 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2007 | 136 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2009 | 493 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 296 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2010 | 491 | 0.020 |
Why?
|
| Calcium | 1 | 2009 | 573 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2007 | 292 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2007 | 384 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2010 | 692 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2036 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 1535 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 14281 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 17416 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 20649 | 0.010 |
Why?
|